News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Sarah Averill Lott

Advertisement

Research Lead, Digital Medicine Society

Articles by Sarah Averill Lott

Open Science and Digital Health: A Brighter Future for Parkinson’s Disease

BySarah Averill Lott,Diane Stephenson,Yuge Xiao
August 16th 2024

Collaborative efforts among researchers, clinicians, and industry are essential to unlock the full potential of digital health in transforming the lives of people with Parkinson's disease.

Advertisement

Latest Updated Articles

  • Open Science and Digital Health: A Brighter Future for Parkinson’s Disease
    Open Science and Digital Health: A Brighter Future for Parkinson’s Disease

    August 16th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement

2

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats

3

Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees

4

Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers

5

Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us